Arcus Capital Partners’s Calithera Biosciences, Inc CALA Stock Holding History

Arcus Capital Partners’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-250	Closed	-$815	–	383
2022 Q4	$815	Buy	+250	New	+$597	﹤0.01%	342

Other funds holding CALA

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Arcus Capital Partners's CALA Position: Q1 2023 in Review

Arcus Capital Partners sold out of Calithera Biosciences, Inc (CALA) in Q1 2023, closing a stake of 250 shares — an estimated $815 sold.

Arcus Capital Partners first reported a position in CALA in Q4 2022 and held it in 1 quarter. The position peaked at $815 in Q4 2022. 2 funds tracked by Wall St. Rank hold CALA as of Q1 2023.

Arcus Capital Partners reported no remaining Calithera Biosciences, Inc position as of Q1 2023 after selling out during the quarter.
Arcus Capital Partners sold 250 Calithera Biosciences, Inc shares in Q1 2023, an estimated $815.
Arcus Capital Partners first reported a position in Calithera Biosciences, Inc in Q4 2022 and held it in 1 quarter.
Arcus Capital Partners's Calithera Biosciences, Inc position peaked at $815 in Q4 2022.
2 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2023.

Based on Arcus Capital Partners's 13F filing for Q1 2023, filed 9 May 2023.